FABBRONI, CHIARA

FABBRONI, CHIARA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma 2021 Sanfilippo R.Casali P. G.Fabbroni C. + Article (author) -
Impact of pathological stratification on the clinical outcomes of advanced well‐differentiated/dedifferentiated liposarcoma treated with trabectedin 2021 Fabbroni C.Ligorio F.Casali P. G.Sanfilippo R. + Article (author) -
Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors 2020 Sanfilippo, RobertaFabbroni, ChiaraFumagalli, ElenaCasali, Paolo G + Article (author) -
Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers 2020 Fabbroni, ChiaraManglaviti, SaraFumagalli, ElenaCasali, Paolo GSanfilippo, Roberta + Article (author) -
Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study 2020 Zattarin, EFabbroni, CLigorio, FCorti, CBernocchi, OSirico, MCurigliano, GDe Braud, FGMVernieri, C + Article (author) -
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives 2019 Vernieri, ClaudioMennitto, AlessiaMaggi, ClaudiaPrisciandaro, MicheleFabbroni, Chiarade Braud, Filippo + Article (author) -
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles 2019 Vernieri, ClaudioPrisciandaro, MicheleMaggi, ClaudiaMennitto, AlessiaFabbroni, ChiaraFarè, Elenade Braud, Filippo + Article (author) -